What Is Prolotherapy? The Earliest Form of Regenerative Medicine, Explained

What is prolotherapy?

Prolotherapy is the oldest form of regenerative medicine in clinical use, and its origin story is worth knowing.

The technique was borrowed from abdominal surgery, where physicians discovered that injecting a dilute sugar solution into tissue could prompt the body to restart a healing response at the injection site. Nearly 100 years ago, a surgeon named Dr. Earl Gedney, whose thumb had been badly injured in a work accident and who had been told by his own colleagues to live with it or change careers, injected that solution directly into the damaged ligaments of his own thumb. The ligament stabilized. He returned to the operating room.

In plain terms, prolotherapy is an injection of dilute sugar water into a site where the body's healing process has stalled. The solution irritates the tissue just enough to signal the body that the repair work isn't finished, and prompts it to try again. The analogy that tends to land with patients: placing traffic cones around a pothole. The cones flag the problem and call the attention of the repair crew. The cones do not bring the asphalt themselves, but without them, the crew never shows up.

What conditions does prolotherapy treat?

Prolotherapy performs best in conditions involving ligament laxity and tendinopathy, two related problems that share a common feature: the body started a healing response and didn't finish it.

Ligaments connect bone to bone and are designed to be strong, tight, and minimally compliant. When a ligament is injured, whether by a single acute event or by repeated low-grade sprains over time, it can become loose even if it remains technically intact. A loose ligament is not a torn ligament, but it is a ligament that is no longer doing its job, something like a rubber band that has been overstretched and will no longer hold its original shape. The clinical challenge is that this kind of laxity cannot be demonstrated on MRI. The only reliable way to identify it is physical examination, and the most conclusive method is physical examination performed while the joint is under live ultrasound visualization, where the examiner can observe the ligament stretching under stress in real time.

Tendons, which connect muscle to bone, can develop a similar pattern of incomplete repair. In tendinopathy, the uniform fibrillar structure of the tendon breaks down: the tendon enlarges, loses tensile strength, and becomes chronically painful. Tennis elbow and jumper's knee are common examples. This cluster of findings represents an incomplete healing response, and prolotherapy has been shown to provide the stimulus needed to push that stalled process toward something more complete.

How does prolotherapy compare to the alternatives?

For most patients with chronic musculoskeletal injuries, the options presented tend to be some version of surgery, cortisone, or regenerative medicine. Prolotherapy is worth understanding in relation to all three.

Prolotherapy vs. surgery

Surgery is the appropriate choice for complete ligament ruptures, full-thickness tendon tears, and cases where the structural anatomy requires reconstruction. For conditions that fall short of that threshold, a non-surgical option should be evaluated before an operation is scheduled. A ligament that is loose but intact is a different clinical problem from a ligament whose two ends are no longer connected, and the two warrant different approaches.

Prolotherapy vs cortisone 

Cortisone occupies an interesting position in this comparison. Corticosteroids reduce inflammation, which sounds like exactly what a painful injury needs. The issue is that inflammation is how the body repairs damaged tissue. A corticosteroid injection in an area of chronic injury signals the body to suspend the healing response, and what the patient receives in exchange is temporary pain relief in a structure that has been left less capable of completing its own repair.

Prolotherapy vs. PRP and other regenerative options

Within the regenerative medicine options, prolotherapy belongs at the front of the menu. If PRP, bone marrow aspirate concentrate, or microfragmented adipose tissue are the main course, prolotherapy is the appetizer. It relies entirely on the body's own response, signaling the need for repair without delivering any external repair material. A good response to prolotherapy is also a meaningful predictor of how well a more advanced regenerative option would perform.

What are the limitations of prolotherapy?

Prolotherapy is not a solution for every chronic soft tissue injury.

It is unlikely to restore stability or function in ligaments or tendons that are fully transected. If the two ends of a structure are no longer connected, stimulating the healing response cannot restore what was never there, and those cases typically require surgical reconstruction. Partial-thickness tears with accompanying laxity are less predictable and evaluated case by case.

Baseline health also matters. Prolotherapy depends on the body's own repair capability, which means patients with poorly managed diabetes, active smoking, or other conditions that impair tissue healing are less likely to respond the same way as an otherwise healthy patient who had a bad injury.

How do physicians decide if prolotherapy is right for you?

Treatment success depends on diagnosis first. A prolotherapy injection delivered to the wrong structure, or for the wrong reason, does not help. A consultation at OASIS is built to confirm the diagnosis before any treatment decision is made.

The physical examination. Ligament laxity cannot be proven on conventional imaging. It has to be identified in the room, testing joint stability under load, and confirming that provoking the laxity reproduces the pain the patient came in describing. That correlation is what establishes the diagnosis.

Ultrasound in the office. Physical examination becomes considerably more conclusive when performed alongside live diagnostic ultrasound. Watching a ligament stretch under stress, or identifying the enlargement and disorganization pattern of tendinopathy on the screen during the examination, resolves ambiguities that imaging reports alone cannot. At OASIS, diagnostic ultrasound is part of every initial consultation, performed in the office without a separate referral or appointment.

The duration of the injury. Prolotherapy is most useful in chronic conditions where the initial healing attempt has stalled. As a general clinical reference point, most soft tissue injuries that are going to resolve on their own will do so within six to eight weeks. An injury that has persisted beyond the two-month mark is a signal that the healing response fell short before the work was done.

What has already been tried. Prior treatments, injections, and surgeries, and the response to each, all inform the evaluation and the risk-benefit conversation.

A responsible evaluation can also conclude that prolotherapy is not the right option, and that PRP, a surgical consult, or a different approach is more appropriate. That conclusion is part of what the consultation is for.

Find out if prolotherapy is right for you. Same-day answers, no referral required.

Request a Consultation

Dr. Matt Kiok, MD, MPH, is the founder of OASIS Regenerative Medicine in Las Vegas, Nevada. He is a physician dedicated to advancing the emerging field of regenerative medicine, with a background in the non-surgical treatment of active adults and performance-driven patients with various orthopedic conditions. His clinical philosophy centers on accurate assessment first: identifying what's actually going on before determining whether regenerative medicine is the right path forward.

This post is intended for educational purposes only and does not constitute medical advice. Individual outcomes vary.